6-Hydroxy-4-quinolinecarboxylic acid cas: 4312-44-1

CAS NO: 4312-44-1
CBNumber: CB02311971
Chemical Name: 6-Hydroxy-4-quinolinecarboxylic acid
Molecular Formula: C10H7NO3
Formula Weight: 189.17
CAS No.: 4312-44-1
Description Review
Description
Heterocyclic compounds are very important in organic chemistry, especially when you think about the uses they have in material science and medicine. 6-Hydroxy-4-quinolinecarboxylic acid, a quinoline derivative with a remarkable range of characteristics and prospective applications, is one such interesting chemical.



The following keywords are popular on Google: "6-Hydroxy-4-quinolinecarboxylic acid applications" , "4312-44-1 molecular research" , "Quinoline derivatives in medicine" , "Organic compounds in drug synthesis" , "Heterocyclic chemistry and pharmaceuticals" .

Similar Products from Competitors
This substance has a close relationship with quinine and chloroquine, two additional therapeutic quinoline derivatives. There are similarities between the bicyclic structures of these compounds; nevertheless, there are differences in the functional groups that they contain, which bestow different characteristics and uses.

Health Advantages and Risks
As a practitioner in the area, you should be aware that 6-hydroxy-4-quinolinecarboxylic acid has importance as a building block in pharmaceutical synthesis even if it isn't directly employed as a medical product. Its structure might be crucial in the development of new medications, particularly those targeting disorders where quinoline-based molecules have shown effectiveness.

How the Product Works
6-Hydroxy-4-quinolinecarboxylic acid, by virtue of its reactive hydroxyl and carboxylic acid groups, is susceptible to a multitude of chemical reactions during chemical synthesis. More complex molecules may be built by these processes, which might lead to drugs with favorable pharmacological properties.

Safety, Side Effects
For the purposes of laboratory handling, 6-Hydroxy-4-quinolinecarboxylic acid's safety profile as a raw material is well-understood. However, the kind of derivative that is made from it determines whether or not it is safe to use in biological systems. As with any chemical, proper safety precautions must be used while handling it.

Information Regarding Dosage and Contraindications
The dosage information and warnings for 6-Hydroxy-4-quinolinecarboxylic acid itself don't apply because it is a chemical used in production and not a straight medicine. The significance of these factors would become apparent when considering its derivatives, taking into account their specific pharmacological objectives and characteristics.

The conclusion is that 6-hydroxy-4-quinolinecarboxylic acid is a product that exemplifies the complexity of organic chemicals and the potential they have to advance medical research. While not a direct medicinal agent, it is crucial to the manufacture of life-saving medications. We could learn more about its properties and potential uses in the medication development industry as research advances.

6-Hydroxy-4-quinolinecarboxylic acid cas: 4312-44-1

"People Also Ask"

Section Q: What are the main applications of 6-hydroxy-4-quinolinecarboxylic acid in the scientific community?
Chemical synthesis and pharmacological studies make extensive use of this molecule. To put it another way, it is a fundamental component in the process of generating more complex molecules, notably in the production of novel pharmaceuticals.

How is 6-Hydroxy-4-quinolinecarboxylic acid made?
A series of intricate organic processes, including hydroxylation and carboxylation stages to add certain functional groups, begin with simpler quinoline molecules and work their way up to more complicated compounds

Q: Are any medications produced from 6-Hydroxy-4-quinolinecarboxylic acid known?
At present, this compound does not yield any direct medicinal derivatives. It could be used to make new medicines, though, because its structure is so flexible.

When working with this substance, what precautions should be followed to ensure safety?
A: It is advised that standard laboratory safety practices be followed, which include the use of personal protective equipment and the provision of adequate ventilation. It is important to use caution while handling the substance in order to prevent exposure and ingestion.



  • "6-Hydroxy-4-quinolinecarboxylic acid synthesis",
  • "Quinoline derivatives in drug design",
  • "Organic synthesis of hydroxyquinoline",
  • "6-Hydroxy-4-quinolinecarboxylic acid properties",
  • "Quinoline ring in pharmaceuticals",
  • "Heterocyclic compounds in chemistry",
  • "Carboxylic acid derivatives in organic chemistry".
    • 6-Hydroxy-4-quinolinecarboxylic acid structure,
    • Quinoline derivatives in pharmaceuticals,
    • Organic synthesis of quinolines,
    • Hydroxylation in medicinal chemistry,
    • Carboxylic acid compounds in drug design,
    • Benzene-pyridine fused rings,
    • Heterocyclic compounds in organic chemistry,
    • Chemical properties of quinolinecarboxylic acid,
    • Pharmaceutical applications of hydroxy quinolines,
    • Advanced organic synthesis techniques.
  •  
Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code